140 related articles for article (PubMed ID: 1059355)
1. Experimental and clinical studies on nucleoside analogs as antitumor agents.
Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH
Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355
[No Abstract] [Full Text] [Related]
2. Antitumor activity of cyclocytidine in a variety of tumors.
Hoshi A; Kanzawa F; Kuretani K
Gan; 1972 Jun; 63(3):353-60. PubMed ID: 5072834
[No Abstract] [Full Text] [Related]
3. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
Burchenal JH; O'Toole T; Kalaher K; Chisholm J
Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
5. The chemotherapy of human and animal acute leukemia.
Goldin A; Sandberg JS; Henderson ES; Newman JW; Frei E; Holland JF
Cancer Chemother Rep; 1971 Nov; 55(4):309-505. PubMed ID: 4945857
[No Abstract] [Full Text] [Related]
6. Murine and human leukemias.
Burchenal JH
Bibl Haematol; 1975; (40):665-77. PubMed ID: 1100047
[TBL] [Abstract][Full Text] [Related]
7. Collateral sensitivity of resistant lines of mouse leukemias L1210 and L5178Y.
Schmid FA; Hutchison DJ
Cancer Res; 1972 Apr; 32(4):808-12. PubMed ID: 5014791
[No Abstract] [Full Text] [Related]
8. Effect of different doses of methotrexate (NSC-740), cytosine arabinoside (NSC-63878), and cyclophosphamide (NSC-26271) on drug resistance in mice with L1210 leukemia.
Schmid FA; Hutchison DJ
Cancer Chemother Rep; 1972 Aug; 56(4):473-81. PubMed ID: 5081590
[No Abstract] [Full Text] [Related]
9. Antitumor activity of P-4055 (elaidic acid-cytarabine) compared to cytarabine in metastatic and s.c. human tumor xenograft models.
Breistøl K; Balzarini J; Sandvold ML; Myhren F; Martinsen M; De Clercq E; Fodstad O
Cancer Res; 1999 Jun; 59(12):2944-9. PubMed ID: 10383159
[TBL] [Abstract][Full Text] [Related]
10. Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213.
Rivera G; Avery T; Roberts DW
Eur J Cancer (1965); 1975 Sep; 11(9):639-47. PubMed ID: 1220978
[No Abstract] [Full Text] [Related]
11. Studies of 6-N-hydroxylamino-9-beta-D-ribofuranosylpurine in mouse leukemia.
Burchenal JH; Dollinger M; Butterbaugh J; Stoll D; Giner-Sorolla A
Biochem Pharmacol; 1967 Mar; 16(3):423-8. PubMed ID: 6034363
[No Abstract] [Full Text] [Related]
12. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878).
Atassi G; Schaus C; Tagnon HJ
Eur J Cancer (1965); 1975 Sep; 11(9):609-14. PubMed ID: 1220976
[No Abstract] [Full Text] [Related]
13. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
Schrecker AW; Goldin A
Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
[No Abstract] [Full Text] [Related]
14. Immunosuppressive activity of methotrexate and arabinosyl cytosine in mice bearing L1210 leukaemia.
Baldini L; Brambilla G; Cavanna M; Parodi S
Br J Pharmacol; 1968 Nov; 34(3):674P-676P. PubMed ID: 5726804
[No Abstract] [Full Text] [Related]
15. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias.
Avery TL; Roberts D
Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479
[No Abstract] [Full Text] [Related]
16. Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
Frei E; Schabel FM; Goldin A
Cancer Res; 1974 Jan; 34(1):184-93. PubMed ID: 4520419
[No Abstract] [Full Text] [Related]
17. The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
Woodman RJ; Sirica AE; Gang M; Kline I; Venditti JM
Chemotherapy; 1973; 18(3):169-83. PubMed ID: 4119363
[No Abstract] [Full Text] [Related]
18. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
Avery TL; Roberts D
Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
[No Abstract] [Full Text] [Related]
19. [Search for biochemical criteria of sensitivity and resistance of tumor cells to antimetabolites].
Belousova AK; Gerasimova GK
Vestn Akad Med Nauk SSSR; 1978; (5):58-64. PubMed ID: 676465
[No Abstract] [Full Text] [Related]
20. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
Schmid FA; Hutchison DJ; Otter GM; Stock CC
Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
